We are live on ! Find out more
BC

Blackhill Capital Portfolio holdings

AUM $1.94B
1-Year Est. Return 18.09%
This Fund
S&P 500
This Quarter Est. Return
+48.81%
1 Year Est. Return
+18.09%
3 Year Est. Return
+164.47%
5 Year Est. Return
+136.25%
10 Year Est. Return
+688.12%
AUM
$1.15B
AUM Growth
+$318M
Cap. Flow
-$2.32M
Cap. Flow %
-0.2%
Top 10 Hldgs %
86.7%
Holding
58
New
Increased
4
Reduced
8
Closed
2

Top Buys

Rank Stock Value
1
ELAN icon
Elanco Animal Health
ELAN
+$4.55M
2
WSM icon
Williams-Sonoma
WSM
+$1.33M
3
AMZN icon
Amazon
AMZN
+$238K
4
ABBV icon
AbbVie
ABBV
+$32.1K

Top Sells

Rank Stock Value
1
TCP
TC Pipelines LP
TCP
+$2.81M
2
PFE icon
Pfizer
PFE
+$2.39M
3
ZTS icon
Zoetis
ZTS
+$1.27M
4
VTRS icon
Viatris
VTRS
+$919K
5
BAX icon
Baxter International
BAX
+$635K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 63.37%
2 Healthcare 23.53%
3 Technology 4.4%
4 Communication Services 3.45%
5 Consumer Staples 1.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSM icon
1
Williams-Sonoma
WSM
$29.5B
$721M 62.89%
8,049,940
+19,680
+0.2% +$1.33M
ABT icon
2
Abbott
ABT
$190B
$38.7M 3.37%
322,830
ZTS icon
3
Zoetis
ZTS
$31.1B
$36.8M 3.21%
233,566
-8,000
-3% -$1.27M
DIS icon
4
Walt Disney
DIS
$179B
$34.9M 3.05%
189,300
AAPL icon
5
Apple
AAPL
$4.45T
$33.4M 2.92%
273,800
-700
-0.3% -$89.9K
LLY icon
6
Eli Lilly
LLY
$1.08T
$27.7M 2.41%
148,023
BMY icon
7
Bristol-Myers Squibb
BMY
$130B
$27M 2.35%
426,964
-2,000
-0.5% -$124K
ABBV icon
8
AbbVie
ABBV
$442B
$26.8M 2.34%
247,560
+300
+0.1% +$32.1K
JNJ icon
9
Johnson & Johnson
JNJ
$626B
$25.7M 2.24%
156,230
MRK icon
10
Merck
MRK
$322B
$22.1M 1.93%
301,038
-3,144
-1% -$232K
ELAN icon
11
Elanco Animal Health
ELAN
$11.4B
$17.1M 1.49%
579,171
+148,000
+34% +$4.55M
MSFT icon
12
Microsoft
MSFT
$3.74T
$16.7M 1.46%
70,850
ZBH icon
13
Zimmer Biomet
ZBH
$18.5B
$15.6M 1.36%
100,322
CAT icon
14
Caterpillar
CAT
$388B
$13.9M 1.21%
60,000
PFE icon
15
Pfizer
PFE
$152B
$11.9M 1.04%
328,239
-67,200
-17% -$2.39M
KMB icon
16
Kimberly-Clark
KMB
$36.1B
$11.8M 1.03%
85,000
BAX icon
17
Baxter International
BAX
$14.3B
$9.63M 0.84%
114,200
-8,000
-7% -$635K
MA icon
18
Mastercard
MA
$492B
$7.12M 0.62%
20,000
PG icon
19
Procter & Gamble
PG
$338B
$6.08M 0.53%
44,871
CI icon
20
Cigna
CI
$72.4B
$5.94M 0.52%
24,587
BRK.B icon
21
Berkshire Hathaway Class B
BRK.B
$1.11T
$4.63M 0.4%
18,108
-2
-0% -$486
AMZN icon
22
Amazon
AMZN
$2.94T
$4.05M 0.35%
26,160
+1,500
+6% +$238K
EPD icon
23
Enterprise Products Partners
EPD
$81.8B
$3.29M 0.29%
149,570
MDT icon
24
Medtronic
MDT
$116B
$2.86M 0.25%
24,177
MMP
25
DELISTED
Magellan Midstream Partners, L.P.
MMP
$2.38M 0.21%
54,800

Similar funds

Blackhill Capital's Q1 2021 Portfolio in Review

As of Q1 2021, Blackhill Capital held 58 positions worth $1.15B, up 38% from $829M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Trading was light in Q1 2021: portfolio turnover was 3.4%. Blackhill Capital opened no new positions and exited 2, leaving the 58-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 63% of assets, up from 50% a quarter earlier, followed by Healthcare and Technology.

  • Blackhill Capital added most to Elanco Animal Health in Q1 2021, an estimated $4.55M increase.
  • Blackhill Capital's biggest Q1 2021 reduction was Pfizer, cutting an estimated $2.39M.
  • Blackhill Capital fully exited TC Pipelines LP in Q1 2021, selling an estimated $2.81M.
  • Blackhill Capital's ten largest holdings make up 87% of its $1.15B portfolio in Q1 2021.
  • Blackhill Capital opened 0 new positions and closed 2 in Q1 2021.
  • Blackhill Capital's portfolio value rose 38% quarter-over-quarter to $1.15B.

Based on Blackhill Capital's 13F filing for Q1 2021, filed 13 May 2021.